IRON stock news
This page provides real-time market news, earnings updates, and company announcements related to Disc Medicine, Inc. (IRON).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-27 14:17 EST

DeepSeek R1 celebrates its first anniversary: focusing on core technology without chasing features, funding, or urgency
爱范儿2026-01-21 02:39:34
Not wanting to fall behind OpenAI, Apple is said to be working on its own AI-powered wearable device
101 finance2026-01-22 00:45:11
Twin Disc: Fiscal Second Quarter Earnings Overview
101 finance2026-02-04 13:24:35
Worksport Confirms Government Evaluation of Aetherlux(TM) Heat Pump for Potential Long-Term Supply Deal; Certification Accelerated
Finviz2026-02-12 13:27:39
CSPi Reports 14.6% Services Revenue Growth, Significantly Expands Gross Margin and Generates FY 2026 First Quarter Profit
Finviz2026-02-12 13:36:12
Nixxy, Inc. Announces Strategic Partnership with PayToMe.co to Accelerate Telco + Fintech Convergence
Finviz2026-02-12 14:03:34
GEE Group Announces Results for the Fiscal 2026 First Quarter Ended December 31, 2025
Finviz2026-02-12 21:33:43

Snow Lake Completes Acquisition of Global Uranium and Enrichment Limited
Finviz2026-02-13 12:33:07

Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
Finviz2026-02-13 20:09:38
The U.S. Food and Drug Administration (FDA) has officially recognized that data submitted from the Aurora and Beacon clinical trials conducted by Disc Medicine sufficiently demonstrate that its investigational drug Bitopertin can significantly reduce protoporphyrin (Ppix) levels in patients' blood.
老虎证券2026-02-13 20:37:48

BioRestorative Announces Closing of $5.0 Million Public Offering
Finviz2026-02-14 01:33:41
FDA Delays Disc Medicine's Rare Disease Drug
Finviz2026-02-17 10:57:36
Disc Medicine executives noted during a conference call that the policy debate over accelerated approval pathways has spanned multiple government administrations.
老虎证券2026-02-17 13:22:59

Eco Wave Power Highlighted in U.S. Department of Energy National Laboratory Report Emphasizing the Strong Economic and Deployment Advantages of Coastal Structure-Integrated Wave Energy
Finviz2026-02-19 13:33:13

Stock Futures Slide as Q4 GDP Misses Estimates
Finviz2026-02-20 14:21:04

FibroBiologics Granted Extension by Nasdaq to Regain Compliance
Finviz2026-02-23 13:34:18

BioRestorative Expands Global Protection for ThermoStem, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs
Finviz2026-02-24 13:33:08

Disc Medicine to Participate in Upcoming Investor Conferences
Finviz2026-02-24 13:33:10

FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-24 21:33:11
BVF's $52M Investment in Disc Medicine: Interpreting the Discrepancy in Expectations Following the FDA CRL
101 finance2026-02-25 21:01:01

Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 13:33:09

FibroBiologics to Present at the BIO Investment & Growth Summit
Finviz2026-02-26 13:33:09

Nexa Resources Reports Adjusted EBITDA of US$772 Million, and US$223 Million Net Income in 2025
Finviz2026-02-26 21:27:03

Stocks Stunted by Hot Inflation Data, Tech Troubles
Finviz2026-02-27 14:21:46
CSPi Reports 14.6% Services Revenue Growth, Significantly Expands Gross Margin and Generates FY 2026 First Quarter Profit
Finviz2026-02-12 13:36:12
Nixxy, Inc. Announces Strategic Partnership with PayToMe.co to Accelerate Telco + Fintech Convergence
Finviz2026-02-12 14:03:34
GEE Group Announces Results for the Fiscal 2026 First Quarter Ended December 31, 2025
Finviz2026-02-12 21:33:43

Snow Lake Completes Acquisition of Global Uranium and Enrichment Limited
Finviz2026-02-13 12:33:07

Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
Finviz2026-02-13 20:09:38
The U.S. Food and Drug Administration (FDA) has officially recognized that data submitted from the Aurora and Beacon clinical trials conducted by Disc Medicine sufficiently demonstrate that its investigational drug Bitopertin can significantly reduce protoporphyrin (Ppix) levels in patients' blood.
老虎证券2026-02-13 20:37:48

BioRestorative Announces Closing of $5.0 Million Public Offering
Finviz2026-02-14 01:33:41
FDA Delays Disc Medicine's Rare Disease Drug
Finviz2026-02-17 10:57:36
Disc Medicine executives noted during a conference call that the policy debate over accelerated approval pathways has spanned multiple government administrations.
老虎证券2026-02-17 13:22:59

Eco Wave Power Highlighted in U.S. Department of Energy National Laboratory Report Emphasizing the Strong Economic and Deployment Advantages of Coastal Structure-Integrated Wave Energy
Finviz2026-02-19 13:33:13

Stock Futures Slide as Q4 GDP Misses Estimates
Finviz2026-02-20 14:21:04

FibroBiologics Granted Extension by Nasdaq to Regain Compliance
Finviz2026-02-23 13:34:18

BioRestorative Expands Global Protection for ThermoStem, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs
Finviz2026-02-24 13:33:08

Disc Medicine to Participate in Upcoming Investor Conferences
Finviz2026-02-24 13:33:10

FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-24 21:33:11
BVF's $52M Investment in Disc Medicine: Interpreting the Discrepancy in Expectations Following the FDA CRL
101 finance2026-02-25 21:01:01

Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 13:33:09

FibroBiologics to Present at the BIO Investment & Growth Summit
Finviz2026-02-26 13:33:09

Nexa Resources Reports Adjusted EBITDA of US$772 Million, and US$223 Million Net Income in 2025
Finviz2026-02-26 21:27:03

Stocks Stunted by Hot Inflation Data, Tech Troubles
Finviz2026-02-27 14:21:46
IRON stock chart
IRON stock detailsIRON stock price change
On the last trading day, IRON stock closed at 66.89 USD, with a price change of 1.04% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more